Song, M.; Zeng, X.; Wu, Q.; Huang, J.; Dong, J.; Shao, L.; Sun, Z.; Lin, Y.; Chen, S.
Metastatic Colorectal Cancer Patient with Microsatellite Stability and Germline BRAC2 Mutation Shows a Complete Response to Olaparib in Combination with a PD-1 Inhibitor and Bevacizumab: A Case Report and Review of the Literature. Life 2023, 13, 1183.
https://doi.org/10.3390/life13051183
AMA Style
Song M, Zeng X, Wu Q, Huang J, Dong J, Shao L, Sun Z, Lin Y, Chen S.
Metastatic Colorectal Cancer Patient with Microsatellite Stability and Germline BRAC2 Mutation Shows a Complete Response to Olaparib in Combination with a PD-1 Inhibitor and Bevacizumab: A Case Report and Review of the Literature. Life. 2023; 13(5):1183.
https://doi.org/10.3390/life13051183
Chicago/Turabian Style
Song, Minghan, Xianrong Zeng, Qian Wu, Jie Huang, Jiayi Dong, Lijuan Shao, Zihao Sun, Yiguang Lin, and Size Chen.
2023. "Metastatic Colorectal Cancer Patient with Microsatellite Stability and Germline BRAC2 Mutation Shows a Complete Response to Olaparib in Combination with a PD-1 Inhibitor and Bevacizumab: A Case Report and Review of the Literature" Life 13, no. 5: 1183.
https://doi.org/10.3390/life13051183
APA Style
Song, M., Zeng, X., Wu, Q., Huang, J., Dong, J., Shao, L., Sun, Z., Lin, Y., & Chen, S.
(2023). Metastatic Colorectal Cancer Patient with Microsatellite Stability and Germline BRAC2 Mutation Shows a Complete Response to Olaparib in Combination with a PD-1 Inhibitor and Bevacizumab: A Case Report and Review of the Literature. Life, 13(5), 1183.
https://doi.org/10.3390/life13051183